nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CES1—Tamoxifen—pancreatic cancer	0.164	0.217	CbGbCtD
Clopidogrel—CES1—Irinotecan—pancreatic cancer	0.126	0.167	CbGbCtD
Clopidogrel—CYP2B6—Tamoxifen—pancreatic cancer	0.0315	0.0417	CbGbCtD
Clopidogrel—CYP3A5—Tamoxifen—pancreatic cancer	0.0248	0.0329	CbGbCtD
Clopidogrel—CYP2B6—Irinotecan—pancreatic cancer	0.0242	0.0321	CbGbCtD
Clopidogrel—CYP2C8—Tamoxifen—pancreatic cancer	0.0239	0.0316	CbGbCtD
Clopidogrel—CYP1A2—Dacarbazine—pancreatic cancer	0.0232	0.0308	CbGbCtD
Clopidogrel—CYP3A5—Erlotinib—pancreatic cancer	0.0211	0.028	CbGbCtD
Clopidogrel—CYP2C8—Erlotinib—pancreatic cancer	0.0203	0.0269	CbGbCtD
Clopidogrel—CYP2C19—Tamoxifen—pancreatic cancer	0.02	0.0265	CbGbCtD
Clopidogrel—CYP3A5—Irinotecan—pancreatic cancer	0.0191	0.0253	CbGbCtD
Clopidogrel—CYP1A2—Tamoxifen—pancreatic cancer	0.0185	0.0245	CbGbCtD
Clopidogrel—CYP2C8—Fluorouracil—pancreatic cancer	0.0176	0.0233	CbGbCtD
Clopidogrel—CYP2C9—Tamoxifen—pancreatic cancer	0.0166	0.0221	CbGbCtD
Clopidogrel—ABCB1—Tamoxifen—pancreatic cancer	0.0162	0.0214	CbGbCtD
Clopidogrel—CYP1A2—Erlotinib—pancreatic cancer	0.0157	0.0208	CbGbCtD
Clopidogrel—CYP3A5—Docetaxel—pancreatic cancer	0.014	0.0185	CbGbCtD
Clopidogrel—ABCB1—Gemcitabine—pancreatic cancer	0.0139	0.0184	CbGbCtD
Clopidogrel—CYP3A5—Sunitinib—pancreatic cancer	0.0139	0.0184	CbGbCtD
Clopidogrel—ABCB1—Erlotinib—pancreatic cancer	0.0137	0.0182	CbGbCtD
Clopidogrel—CYP1A2—Fluorouracil—pancreatic cancer	0.0136	0.018	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—pancreatic cancer	0.0132	0.0175	CbGbCtD
Clopidogrel—ABCB1—Irinotecan—pancreatic cancer	0.0124	0.0164	CbGbCtD
Clopidogrel—CYP2C9—Fluorouracil—pancreatic cancer	0.0123	0.0163	CbGbCtD
Clopidogrel—CYP3A4—Tamoxifen—pancreatic cancer	0.00968	0.0128	CbGbCtD
Clopidogrel—ABCB1—Docetaxel—pancreatic cancer	0.00909	0.012	CbGbCtD
Clopidogrel—ABCB1—Sunitinib—pancreatic cancer	0.00905	0.012	CbGbCtD
Clopidogrel—CYP3A4—Erlotinib—pancreatic cancer	0.00823	0.0109	CbGbCtD
Clopidogrel—CYP3A4—Irinotecan—pancreatic cancer	0.00743	0.00985	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—pancreatic cancer	0.00678	0.00898	CbGbCtD
Clopidogrel—CYP3A4—Docetaxel—pancreatic cancer	0.00545	0.00722	CbGbCtD
Clopidogrel—CYP3A4—Sunitinib—pancreatic cancer	0.00542	0.00718	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—pancreatic cancer	0.00406	0.00538	CbGbCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000128	0.000599	CcSEcCtD
Clopidogrel—Angina pectoris—Epirubicin—pancreatic cancer	0.000127	0.000597	CcSEcCtD
Clopidogrel—Abdominal pain—Irinotecan—pancreatic cancer	0.000126	0.00059	CcSEcCtD
Clopidogrel—Body temperature increased—Irinotecan—pancreatic cancer	0.000126	0.00059	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000126	0.00059	CcSEcCtD
Clopidogrel—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000126	0.00059	CcSEcCtD
Clopidogrel—Bronchitis—Epirubicin—pancreatic cancer	0.000126	0.000589	CcSEcCtD
Clopidogrel—Anaemia—Docetaxel—pancreatic cancer	0.000125	0.000585	CcSEcCtD
Clopidogrel—Pancytopenia—Epirubicin—pancreatic cancer	0.000124	0.000582	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—pancreatic cancer	0.000124	0.00058	CcSEcCtD
Clopidogrel—Vomiting—Sunitinib—pancreatic cancer	0.000123	0.000577	CcSEcCtD
Clopidogrel—Body temperature increased—Gemcitabine—pancreatic cancer	0.000123	0.000575	CcSEcCtD
Clopidogrel—Neutropenia—Epirubicin—pancreatic cancer	0.000122	0.000573	CcSEcCtD
Clopidogrel—Rash—Sunitinib—pancreatic cancer	0.000122	0.000572	CcSEcCtD
Clopidogrel—Dermatitis—Sunitinib—pancreatic cancer	0.000122	0.000571	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—pancreatic cancer	0.000122	0.00057	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000121	0.000569	CcSEcCtD
Clopidogrel—Urticaria—Fluorouracil—pancreatic cancer	0.000121	0.000568	CcSEcCtD
Clopidogrel—Headache—Sunitinib—pancreatic cancer	0.000121	0.000568	CcSEcCtD
Clopidogrel—Syncope—Docetaxel—pancreatic cancer	0.000121	0.000567	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—pancreatic cancer	0.000121	0.000567	CcSEcCtD
Clopidogrel—Leukopenia—Docetaxel—pancreatic cancer	0.000121	0.000566	CcSEcCtD
Clopidogrel—Body temperature increased—Fluorouracil—pancreatic cancer	0.000121	0.000566	CcSEcCtD
Clopidogrel—Eosinophilia—Doxorubicin—pancreatic cancer	0.00012	0.000561	CcSEcCtD
Clopidogrel—Palpitations—Docetaxel—pancreatic cancer	0.000119	0.000559	CcSEcCtD
Clopidogrel—Loss of consciousness—Docetaxel—pancreatic cancer	0.000119	0.000556	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—pancreatic cancer	0.000119	0.000556	CcSEcCtD
Clopidogrel—Cough—Docetaxel—pancreatic cancer	0.000118	0.000552	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—pancreatic cancer	0.000118	0.000552	CcSEcCtD
Clopidogrel—Hypersensitivity—Irinotecan—pancreatic cancer	0.000117	0.00055	CcSEcCtD
Clopidogrel—Pneumonia—Epirubicin—pancreatic cancer	0.000117	0.000549	CcSEcCtD
Clopidogrel—Hypertension—Docetaxel—pancreatic cancer	0.000117	0.000546	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—pancreatic cancer	0.000116	0.000545	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000115	0.000541	CcSEcCtD
Clopidogrel—Chest pain—Docetaxel—pancreatic cancer	0.000115	0.000539	CcSEcCtD
Clopidogrel—Arthralgia—Docetaxel—pancreatic cancer	0.000115	0.000539	CcSEcCtD
Clopidogrel—Myalgia—Docetaxel—pancreatic cancer	0.000115	0.000539	CcSEcCtD
Clopidogrel—Nausea—Sunitinib—pancreatic cancer	0.000115	0.000539	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—pancreatic cancer	0.000115	0.000538	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—pancreatic cancer	0.000114	0.000537	CcSEcCtD
Clopidogrel—Asthenia—Irinotecan—pancreatic cancer	0.000114	0.000536	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000114	0.000535	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000114	0.000535	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—pancreatic cancer	0.000114	0.000532	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—pancreatic cancer	0.000113	0.000531	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—pancreatic cancer	0.000113	0.000531	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—pancreatic cancer	0.000113	0.00053	CcSEcCtD
Clopidogrel—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000112	0.000527	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000112	0.000527	CcSEcCtD
Clopidogrel—Asthenia—Gemcitabine—pancreatic cancer	0.000111	0.000522	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—pancreatic cancer	0.000111	0.000521	CcSEcCtD
Clopidogrel—Confusional state—Docetaxel—pancreatic cancer	0.000111	0.000521	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00011	0.000516	CcSEcCtD
Clopidogrel—Oedema—Docetaxel—pancreatic cancer	0.00011	0.000516	CcSEcCtD
Clopidogrel—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00011	0.000516	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—pancreatic cancer	0.00011	0.000515	CcSEcCtD
Clopidogrel—Pruritus—Gemcitabine—pancreatic cancer	0.00011	0.000515	CcSEcCtD
Clopidogrel—Infection—Docetaxel—pancreatic cancer	0.000109	0.000513	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—pancreatic cancer	0.000109	0.000512	CcSEcCtD
Clopidogrel—Diarrhoea—Irinotecan—pancreatic cancer	0.000109	0.000511	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—pancreatic cancer	0.000109	0.00051	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—pancreatic cancer	0.000108	0.000508	CcSEcCtD
Clopidogrel—Shock—Docetaxel—pancreatic cancer	0.000108	0.000508	CcSEcCtD
Clopidogrel—Nervous system disorder—Docetaxel—pancreatic cancer	0.000108	0.000506	CcSEcCtD
Clopidogrel—Pruritus—Fluorouracil—pancreatic cancer	0.000108	0.000506	CcSEcCtD
Clopidogrel—Skin disorder—Docetaxel—pancreatic cancer	0.000107	0.000502	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000107	0.000501	CcSEcCtD
Clopidogrel—Diarrhoea—Gemcitabine—pancreatic cancer	0.000106	0.000498	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—pancreatic cancer	0.000106	0.000497	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000106	0.000495	CcSEcCtD
Clopidogrel—Dizziness—Irinotecan—pancreatic cancer	0.000105	0.000494	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—pancreatic cancer	0.000105	0.000493	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—pancreatic cancer	0.000105	0.000493	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—pancreatic cancer	0.000105	0.000491	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000105	0.000491	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000105	0.000491	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—pancreatic cancer	0.000105	0.00049	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—pancreatic cancer	0.000105	0.00049	CcSEcCtD
Clopidogrel—Diarrhoea—Fluorouracil—pancreatic cancer	0.000104	0.000489	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000104	0.000488	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000103	0.000484	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—pancreatic cancer	0.000103	0.000483	CcSEcCtD
Clopidogrel—Hypotension—Docetaxel—pancreatic cancer	0.000103	0.000483	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—pancreatic cancer	0.000103	0.000482	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—pancreatic cancer	0.000102	0.000481	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000102	0.000478	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—pancreatic cancer	0.000102	0.000477	CcSEcCtD
Clopidogrel—Vomiting—Irinotecan—pancreatic cancer	0.000101	0.000475	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—pancreatic cancer	0.000101	0.000474	CcSEcCtD
Clopidogrel—Dizziness—Fluorouracil—pancreatic cancer	0.000101	0.000473	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—pancreatic cancer	0.000101	0.000472	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000101	0.000472	CcSEcCtD
Clopidogrel—Rash—Irinotecan—pancreatic cancer	0.0001	0.000471	CcSEcCtD
Clopidogrel—Dermatitis—Irinotecan—pancreatic cancer	0.0001	0.000471	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.0001	0.00047	CcSEcCtD
Clopidogrel—Headache—Irinotecan—pancreatic cancer	9.98e-05	0.000468	CcSEcCtD
Clopidogrel—Insomnia—Docetaxel—pancreatic cancer	9.96e-05	0.000467	CcSEcCtD
Clopidogrel—Paraesthesia—Docetaxel—pancreatic cancer	9.89e-05	0.000464	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—pancreatic cancer	9.89e-05	0.000464	CcSEcCtD
Clopidogrel—Vomiting—Gemcitabine—pancreatic cancer	9.87e-05	0.000463	CcSEcCtD
Clopidogrel—Dyspnoea—Docetaxel—pancreatic cancer	9.82e-05	0.00046	CcSEcCtD
Clopidogrel—Rash—Gemcitabine—pancreatic cancer	9.78e-05	0.000459	CcSEcCtD
Clopidogrel—Dermatitis—Gemcitabine—pancreatic cancer	9.78e-05	0.000458	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—pancreatic cancer	9.77e-05	0.000458	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—pancreatic cancer	9.75e-05	0.000457	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—pancreatic cancer	9.72e-05	0.000456	CcSEcCtD
Clopidogrel—Headache—Gemcitabine—pancreatic cancer	9.72e-05	0.000456	CcSEcCtD
Clopidogrel—Vomiting—Fluorouracil—pancreatic cancer	9.7e-05	0.000455	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—pancreatic cancer	9.7e-05	0.000455	CcSEcCtD
Clopidogrel—Dyspepsia—Docetaxel—pancreatic cancer	9.69e-05	0.000455	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—pancreatic cancer	9.67e-05	0.000454	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—pancreatic cancer	9.67e-05	0.000454	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.63e-05	0.000451	CcSEcCtD
Clopidogrel—Rash—Fluorouracil—pancreatic cancer	9.62e-05	0.000451	CcSEcCtD
Clopidogrel—Dermatitis—Fluorouracil—pancreatic cancer	9.61e-05	0.000451	CcSEcCtD
Clopidogrel—Headache—Fluorouracil—pancreatic cancer	9.56e-05	0.000448	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—pancreatic cancer	9.55e-05	0.000448	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—pancreatic cancer	9.53e-05	0.000447	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.51e-05	0.000446	CcSEcCtD
Clopidogrel—Fatigue—Docetaxel—pancreatic cancer	9.49e-05	0.000445	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—pancreatic cancer	9.49e-05	0.000445	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—pancreatic cancer	9.48e-05	0.000445	CcSEcCtD
Clopidogrel—Nausea—Irinotecan—pancreatic cancer	9.46e-05	0.000444	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—pancreatic cancer	9.44e-05	0.000443	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—pancreatic cancer	9.42e-05	0.000442	CcSEcCtD
Clopidogrel—Pain—Docetaxel—pancreatic cancer	9.42e-05	0.000442	CcSEcCtD
Clopidogrel—Constipation—Docetaxel—pancreatic cancer	9.42e-05	0.000442	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—pancreatic cancer	9.32e-05	0.000437	CcSEcCtD
Clopidogrel—Nausea—Gemcitabine—pancreatic cancer	9.22e-05	0.000432	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—pancreatic cancer	9.16e-05	0.000429	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—pancreatic cancer	9.15e-05	0.000429	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—pancreatic cancer	9.1e-05	0.000427	CcSEcCtD
Clopidogrel—Feeling abnormal—Docetaxel—pancreatic cancer	9.08e-05	0.000426	CcSEcCtD
Clopidogrel—Nausea—Fluorouracil—pancreatic cancer	9.06e-05	0.000425	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—pancreatic cancer	9.04e-05	0.000424	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—pancreatic cancer	9.02e-05	0.000423	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.01e-05	0.000422	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—pancreatic cancer	8.97e-05	0.000421	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—pancreatic cancer	8.8e-05	0.000413	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—pancreatic cancer	8.78e-05	0.000412	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—pancreatic cancer	8.75e-05	0.00041	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—pancreatic cancer	8.74e-05	0.00041	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—pancreatic cancer	8.72e-05	0.000409	CcSEcCtD
Clopidogrel—Abdominal pain—Docetaxel—pancreatic cancer	8.71e-05	0.000408	CcSEcCtD
Clopidogrel—Body temperature increased—Docetaxel—pancreatic cancer	8.71e-05	0.000408	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—pancreatic cancer	8.48e-05	0.000397	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—pancreatic cancer	8.42e-05	0.000395	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—pancreatic cancer	8.41e-05	0.000394	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—pancreatic cancer	8.3e-05	0.000389	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—pancreatic cancer	8.18e-05	0.000383	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—pancreatic cancer	8.16e-05	0.000383	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—pancreatic cancer	8.15e-05	0.000382	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—pancreatic cancer	8.15e-05	0.000382	CcSEcCtD
Clopidogrel—Hypersensitivity—Docetaxel—pancreatic cancer	8.11e-05	0.00038	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—pancreatic cancer	8.1e-05	0.00038	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—pancreatic cancer	8.04e-05	0.000377	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—pancreatic cancer	8e-05	0.000375	CcSEcCtD
Clopidogrel—Cough—Epirubicin—pancreatic cancer	7.94e-05	0.000372	CcSEcCtD
Clopidogrel—Asthenia—Docetaxel—pancreatic cancer	7.9e-05	0.00037	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—pancreatic cancer	7.86e-05	0.000368	CcSEcCtD
Clopidogrel—Pruritus—Docetaxel—pancreatic cancer	7.79e-05	0.000365	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—pancreatic cancer	7.78e-05	0.000365	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—pancreatic cancer	7.75e-05	0.000363	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—pancreatic cancer	7.75e-05	0.000363	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—pancreatic cancer	7.75e-05	0.000363	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—pancreatic cancer	7.72e-05	0.000362	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.7e-05	0.000361	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—pancreatic cancer	7.57e-05	0.000355	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—pancreatic cancer	7.55e-05	0.000354	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—pancreatic cancer	7.54e-05	0.000353	CcSEcCtD
Clopidogrel—Diarrhoea—Docetaxel—pancreatic cancer	7.54e-05	0.000353	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—pancreatic cancer	7.49e-05	0.000351	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—pancreatic cancer	7.44e-05	0.000349	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—pancreatic cancer	7.43e-05	0.000348	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—pancreatic cancer	7.43e-05	0.000348	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—pancreatic cancer	7.4e-05	0.000347	CcSEcCtD
Clopidogrel—Infection—Epirubicin—pancreatic cancer	7.38e-05	0.000346	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—pancreatic cancer	7.35e-05	0.000345	CcSEcCtD
Clopidogrel—Shock—Epirubicin—pancreatic cancer	7.31e-05	0.000343	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—pancreatic cancer	7.28e-05	0.000342	CcSEcCtD
Clopidogrel—Dizziness—Docetaxel—pancreatic cancer	7.28e-05	0.000341	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—pancreatic cancer	7.27e-05	0.000341	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—pancreatic cancer	7.22e-05	0.000338	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—pancreatic cancer	7.17e-05	0.000336	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—pancreatic cancer	7.17e-05	0.000336	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—pancreatic cancer	7.17e-05	0.000336	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—pancreatic cancer	7.15e-05	0.000335	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.12e-05	0.000334	CcSEcCtD
Clopidogrel—Vomiting—Docetaxel—pancreatic cancer	7e-05	0.000328	CcSEcCtD
Clopidogrel—Rash—Docetaxel—pancreatic cancer	6.94e-05	0.000326	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—pancreatic cancer	6.94e-05	0.000325	CcSEcCtD
Clopidogrel—Dermatitis—Docetaxel—pancreatic cancer	6.94e-05	0.000325	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—pancreatic cancer	6.93e-05	0.000325	CcSEcCtD
Clopidogrel—Headache—Docetaxel—pancreatic cancer	6.9e-05	0.000323	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.87e-05	0.000322	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—pancreatic cancer	6.87e-05	0.000322	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—pancreatic cancer	6.83e-05	0.00032	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.77e-05	0.000317	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—pancreatic cancer	6.76e-05	0.000317	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—pancreatic cancer	6.74e-05	0.000316	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—pancreatic cancer	6.72e-05	0.000315	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—pancreatic cancer	6.68e-05	0.000313	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—pancreatic cancer	6.67e-05	0.000313	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—pancreatic cancer	6.62e-05	0.000311	CcSEcCtD
Clopidogrel—Nausea—Docetaxel—pancreatic cancer	6.54e-05	0.000307	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—pancreatic cancer	6.54e-05	0.000307	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—pancreatic cancer	6.42e-05	0.000301	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.41e-05	0.000301	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—pancreatic cancer	6.4e-05	0.0003	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—pancreatic cancer	6.35e-05	0.000298	CcSEcCtD
Clopidogrel—Pain—Epirubicin—pancreatic cancer	6.35e-05	0.000298	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.26e-05	0.000294	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—pancreatic cancer	6.22e-05	0.000291	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—pancreatic cancer	6.17e-05	0.000289	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—pancreatic cancer	6.13e-05	0.000287	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—pancreatic cancer	6.12e-05	0.000287	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.07e-05	0.000285	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—pancreatic cancer	6.05e-05	0.000284	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.93e-05	0.000278	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—pancreatic cancer	5.93e-05	0.000278	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—pancreatic cancer	5.9e-05	0.000277	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—pancreatic cancer	5.88e-05	0.000276	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—pancreatic cancer	5.88e-05	0.000276	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—pancreatic cancer	5.87e-05	0.000275	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—pancreatic cancer	5.87e-05	0.000275	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—pancreatic cancer	5.66e-05	0.000266	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.62e-05	0.000264	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—pancreatic cancer	5.47e-05	0.000257	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—pancreatic cancer	5.46e-05	0.000256	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—pancreatic cancer	5.43e-05	0.000255	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—pancreatic cancer	5.43e-05	0.000255	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—pancreatic cancer	5.33e-05	0.00025	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—pancreatic cancer	5.26e-05	0.000246	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—pancreatic cancer	5.08e-05	0.000238	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—pancreatic cancer	5.06e-05	0.000237	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—pancreatic cancer	4.93e-05	0.000231	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—pancreatic cancer	4.91e-05	0.00023	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—pancreatic cancer	4.86e-05	0.000228	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—pancreatic cancer	4.72e-05	0.000221	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—pancreatic cancer	4.7e-05	0.00022	CcSEcCtD
Clopidogrel—Rash—Epirubicin—pancreatic cancer	4.68e-05	0.00022	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—pancreatic cancer	4.68e-05	0.000219	CcSEcCtD
Clopidogrel—Headache—Epirubicin—pancreatic cancer	4.65e-05	0.000218	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—pancreatic cancer	4.55e-05	0.000213	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—pancreatic cancer	4.41e-05	0.000207	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—pancreatic cancer	4.37e-05	0.000205	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—pancreatic cancer	4.33e-05	0.000203	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—pancreatic cancer	4.33e-05	0.000203	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—pancreatic cancer	4.31e-05	0.000202	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—pancreatic cancer	4.08e-05	0.000191	CcSEcCtD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.4e-05	0.000754	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.38e-05	0.000746	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PRSS1—pancreatic cancer	2.33e-05	0.000732	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SMAD4—pancreatic cancer	2.31e-05	0.000724	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.3e-05	0.000722	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—PIK3CA—pancreatic cancer	2.29e-05	0.000719	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CXCL8—pancreatic cancer	2.28e-05	0.000716	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PRSS1—pancreatic cancer	2.28e-05	0.000716	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HES1—pancreatic cancer	2.25e-05	0.000707	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—pancreatic cancer	2.22e-05	0.000696	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CB—pancreatic cancer	2.16e-05	0.000677	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—HRAS—pancreatic cancer	2.12e-05	0.000665	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.1e-05	0.000658	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.08e-05	0.000652	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CXCL8—pancreatic cancer	2.07e-05	0.000651	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ARG2—pancreatic cancer	2.02e-05	0.000635	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ARG2—pancreatic cancer	1.98e-05	0.000621	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PRSS1—pancreatic cancer	1.98e-05	0.00062	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TERT—pancreatic cancer	1.97e-05	0.00062	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HIF1A—pancreatic cancer	1.89e-05	0.000592	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TSC2—pancreatic cancer	1.88e-05	0.000591	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—AKT1—pancreatic cancer	1.87e-05	0.000588	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—APOE—pancreatic cancer	1.84e-05	0.000578	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KDR—pancreatic cancer	1.81e-05	0.000567	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—TYMP—pancreatic cancer	1.77e-05	0.000555	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.77e-05	0.000554	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PRSS1—pancreatic cancer	1.76e-05	0.000553	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—TYMP—pancreatic cancer	1.73e-05	0.000542	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.72e-05	0.00054	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NFKBIA—pancreatic cancer	1.72e-05	0.000539	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ARG2—pancreatic cancer	1.71e-05	0.000538	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NOTCH1—pancreatic cancer	1.7e-05	0.000534	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CG—pancreatic cancer	1.66e-05	0.000522	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—NRAS—pancreatic cancer	1.66e-05	0.000522	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EGF—pancreatic cancer	1.64e-05	0.000516	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.64e-05	0.000515	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.61e-05	0.000505	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.6e-05	0.000501	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.58e-05	0.000496	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.54e-05	0.000483	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.53e-05	0.00048	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—EGFR—pancreatic cancer	1.52e-05	0.000476	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.5e-05	0.00047	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ARG2—pancreatic cancer	1.49e-05	0.000468	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CD—pancreatic cancer	1.46e-05	0.000459	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.45e-05	0.000455	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—KRAS—pancreatic cancer	1.43e-05	0.000449	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.43e-05	0.000448	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GLP1R—pancreatic cancer	1.43e-05	0.000447	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—DPYD—pancreatic cancer	1.4e-05	0.00044	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.39e-05	0.000438	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.39e-05	0.000437	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.39e-05	0.000437	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.37e-05	0.000431	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.37e-05	0.00043	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.34e-05	0.000419	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	1.33e-05	0.000418	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CA—pancreatic cancer	1.32e-05	0.000413	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TYMP—pancreatic cancer	1.3e-05	0.000409	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.3e-05	0.000408	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.28e-05	0.000402	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.28e-05	0.000401	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CB—pancreatic cancer	1.27e-05	0.0004	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.25e-05	0.000393	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.24e-05	0.000388	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCL8—pancreatic cancer	1.22e-05	0.000384	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.22e-05	0.000382	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—HRAS—pancreatic cancer	1.22e-05	0.000382	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.21e-05	0.000379	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.19e-05	0.000374	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.19e-05	0.000374	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.19e-05	0.000373	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—AKT1—pancreatic cancer	1.18e-05	0.000371	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.18e-05	0.000371	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CASP3—pancreatic cancer	1.17e-05	0.000368	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—pancreatic cancer	1.14e-05	0.000358	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CTNNB1—pancreatic cancer	1.13e-05	0.000355	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.13e-05	0.000354	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.12e-05	0.00035	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MMP9—pancreatic cancer	1.11e-05	0.000348	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.1e-05	0.000346	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	0.000346	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.09e-05	0.000341	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.08e-05	0.000338	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.08e-05	0.000338	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—AKT1—pancreatic cancer	1.07e-05	0.000337	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.06e-05	0.000333	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.06e-05	0.000333	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.05e-05	0.00033	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.05e-05	0.00033	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.04e-05	0.000327	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—DPYD—pancreatic cancer	1.03e-05	0.000325	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CD44—pancreatic cancer	1.03e-05	0.000323	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	0.000321	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CD44—pancreatic cancer	1.01e-05	0.000316	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.01e-05	0.000316	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.01e-05	0.000316	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.95e-06	0.000312	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—pancreatic cancer	9.95e-06	0.000312	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GCG—pancreatic cancer	9.88e-06	0.00031	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STAT3—pancreatic cancer	9.85e-06	0.000309	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NRAS—pancreatic cancer	9.83e-06	0.000308	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GLP1R—pancreatic cancer	9.82e-06	0.000308	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SLC2A2—pancreatic cancer	9.82e-06	0.000308	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.8e-06	0.000308	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—DPYD—pancreatic cancer	9.66e-06	0.000303	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GCG—pancreatic cancer	9.66e-06	0.000303	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.61e-06	0.000301	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—STK11—pancreatic cancer	9.29e-06	0.000292	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.2e-06	0.000289	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	9.17e-06	0.000288	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—pancreatic cancer	9.15e-06	0.000287	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TGFB1—pancreatic cancer	9.13e-06	0.000287	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—STK11—pancreatic cancer	9.08e-06	0.000285	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.08e-06	0.000285	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EGFR—pancreatic cancer	8.95e-06	0.000281	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.88e-06	0.000279	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.76e-06	0.000275	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.75e-06	0.000275	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CD44—pancreatic cancer	8.73e-06	0.000274	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.59e-06	0.00027	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.55e-06	0.000268	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.47e-06	0.000266	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KRAS—pancreatic cancer	8.46e-06	0.000265	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GLP1R—pancreatic cancer	8.39e-06	0.000263	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GCG—pancreatic cancer	8.37e-06	0.000263	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—DPYD—pancreatic cancer	8.26e-06	0.000259	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.04e-06	0.000252	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—TYMS—pancreatic cancer	7.99e-06	0.000251	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.98e-06	0.00025	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—STK11—pancreatic cancer	7.87e-06	0.000247	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	7.84e-06	0.000246	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—TYMS—pancreatic cancer	7.81e-06	0.000245	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CD44—pancreatic cancer	7.79e-06	0.000244	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CA—pancreatic cancer	7.77e-06	0.000244	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.76e-06	0.000243	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.63e-06	0.000239	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CD44—pancreatic cancer	7.6e-06	0.000239	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.56e-06	0.000237	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—pancreatic cancer	7.52e-06	0.000236	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.49e-06	0.000235	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GCG—pancreatic cancer	7.47e-06	0.000234	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.38e-06	0.000232	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GCG—pancreatic cancer	7.29e-06	0.000229	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HRAS—pancreatic cancer	7.19e-06	0.000226	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CD44—pancreatic cancer	7.1e-06	0.000223	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—STK11—pancreatic cancer	7.02e-06	0.00022	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.95e-06	0.000218	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.89e-06	0.000216	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—STK11—pancreatic cancer	6.85e-06	0.000215	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.82e-06	0.000214	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GCG—pancreatic cancer	6.81e-06	0.000214	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.77e-06	0.000212	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.59e-06	0.000207	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—APOE—pancreatic cancer	6.5e-06	0.000204	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.48e-06	0.000203	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—STK11—pancreatic cancer	6.4e-06	0.000201	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.37e-06	0.0002	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—APOE—pancreatic cancer	6.35e-06	0.000199	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—AKT1—pancreatic cancer	6.35e-06	0.000199	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CD44—pancreatic cancer	6.07e-06	0.00019	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.05e-06	0.00019	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TYMS—pancreatic cancer	6.04e-06	0.00019	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.01e-06	0.000189	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.94e-06	0.000186	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TYMS—pancreatic cancer	5.9e-06	0.000185	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.89e-06	0.000185	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	5.87e-06	0.000184	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GCG—pancreatic cancer	5.82e-06	0.000183	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	5.73e-06	0.00018	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PPARG—pancreatic cancer	5.66e-06	0.000178	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PPARG—pancreatic cancer	5.53e-06	0.000174	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.51e-06	0.000173	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—APOE—pancreatic cancer	5.5e-06	0.000173	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—STK11—pancreatic cancer	5.47e-06	0.000172	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.21e-06	0.000163	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	5.16e-06	0.000162	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.14e-06	0.000161	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	5.04e-06	0.000158	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.97e-06	0.000156	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—APOE—pancreatic cancer	4.91e-06	0.000154	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—APOE—pancreatic cancer	4.79e-06	0.00015	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.79e-06	0.00015	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.71e-06	0.000148	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CD44—pancreatic cancer	4.68e-06	0.000147	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.65e-06	0.000146	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	4.5e-06	0.000141	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GCG—pancreatic cancer	4.49e-06	0.000141	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—APOE—pancreatic cancer	4.48e-06	0.000141	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS2—pancreatic cancer	4.45e-06	0.00014	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.43e-06	0.000139	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	4.39e-06	0.000138	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.37e-06	0.000137	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS2—pancreatic cancer	4.35e-06	0.000137	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.33e-06	0.000136	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PPARG—pancreatic cancer	4.28e-06	0.000134	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.24e-06	0.000133	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—STK11—pancreatic cancer	4.22e-06	0.000132	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PPARG—pancreatic cancer	4.18e-06	0.000131	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.04e-06	0.000127	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.9e-06	0.000122	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.9e-06	0.000122	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.88e-06	0.000122	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—APOE—pancreatic cancer	3.83e-06	0.00012	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.81e-06	0.000119	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.8e-06	0.000119	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.8e-06	0.000119	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.77e-06	0.000118	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.63e-06	0.000114	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.62e-06	0.000114	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.55e-06	0.000111	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.45e-06	0.000108	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.4e-06	0.000107	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.37e-06	0.000106	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.33e-06	0.000105	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.32e-06	0.000104	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.29e-06	0.000103	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.29e-06	0.000103	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.1e-06	9.72e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.07e-06	9.63e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.04e-06	9.53e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—APOE—pancreatic cancer	2.95e-06	9.27e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.94e-06	9.21e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTEN—pancreatic cancer	2.86e-06	8.99e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.74e-06	8.6e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.68e-06	8.4e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.68e-06	8.4e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.67e-06	8.36e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.65e-06	8.3e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.62e-06	8.23e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.57e-06	8.07e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.34e-06	7.35e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.32e-06	7.28e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.29e-06	7.18e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKT1—pancreatic cancer	2.24e-06	7.02e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.19e-06	6.87e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.07e-06	6.5e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.04e-06	6.41e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.02e-06	6.35e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.02e-06	6.34e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.9e-06	5.95e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	5.92e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.77e-06	5.54e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.69e-06	5.31e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKT1—pancreatic cancer	1.65e-06	5.18e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.61e-06	5.06e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.54e-06	4.84e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.32e-06	4.14e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.25e-06	3.91e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.02e-06	3.19e-05	CbGpPWpGaD
